GSEA for GO and KEGG enrichment showed that RA patients in the high-risk group with higher levels of B-cell activation and RA characteristics, which revealed that FAS, GPR183, and TFRC were the hub genes and the abnormal expression of these genes were likely to have important pathological effects in RA development. This evidence concerns the gene GPR183 and rheumatoid arthritis.